Categories: Web and IT News

Cell Therapy Technology Market is expected to reach $8.7 Billion by 2028 – An exclusive market research report by Lucintel

Trends and Forecast for the Cell Therapy Technology Market
Trends, opportunities, and forecast for the global cell therapy technology market from 2017 to 2028 by product (media, sera, and reagents, cell engineering products, cell culture vessels, cell therapy equipment, and others), process (cell processing, cell preservation, distribution and handling, and process monitoring and quality control), cell type (T-cell, stem cell, and others), end use industry (biopharmaceutical and biotechnology companies, and others), and region

Lucintel’s latest market report analyzed that cell therapy technology provides attractive opportunities in biopharmaceutical and biotechnology companies, CROs & CMOs, and research institutes & cell banks. The cell therapy technology market is expected to reach $8.7 billion by 2028 with a CAGR of 14.5%. In this market, stem cell is the largest segment by cell type, whereas research institutes and cell bank is largest by end use industry.

Download Brochure of this report by clicking on https://www.lucintel.com/cell-therapy-technology-market.aspx

Based on cell type, the cell therapy technology market is segmented into T-cell, stem cell, and others. The stem cell segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to the increasing need for therapies for neurological diseases and growing awareness of stem cell storage.

Browse in-depth TOC on “Cell Therapy Technology Market”

100 – Figures/Tables

150 – Pages

The Cell Therapy Technology Market is marked by the presence of several big and small players. Some of the prominent players offering cell therapy technology include Pharmicell, Corestem, Chiesi Farmaceutici, Tego Science, and Anterogen.

Request Sample Report:

https://www.lucintel.com/cell-therapy-technology-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com  Tel. 972.636.5056

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

The post Cell Therapy Technology Market is expected to reach $8.7 Billion by 2028 – An exclusive market research report by Lucintel first appeared on PressRelease.cc.

Cell Therapy Technology Market is expected to reach $8.7 Billion by 2028 – An exclusive market research report by Lucintel first appeared on Web and IT News.

awnewsor

Recent Posts

Addigy Puts AI Inside Apple Device Management — But Keeps Admins in Charge

Apple device fleets keep growing inside enterprises and managed service providers. So do the headaches…

13 hours ago

Cisco Identity Services Engine Zero-Day (CVE-2025-20281) Actively Exploited — Patch Immediately

Cisco has disclosed a maximum-severity zero-day vulnerability in its Identity Services Engine that is already…

13 hours ago

Microsoft’s September Patch Triggers Domain Trust Failures on Windows 11

Enterprise IT teams woke up this week to a familiar headache. Domain-joined Windows 11 machines…

13 hours ago

CISOs Confront Autonomous AI Agents That Hack, Spend and Break Production Systems

Attackers exploit new flaws in five days. Most companies patch them in 43. The gap…

13 hours ago

Moonshot’s Kimi AI Breaks Into Chinese Finance With Direct Data Hooks

Beijing-based Moonshot AI didn’t wait for permission. On September 17 the startup rolled out a…

13 hours ago

Microsoft’s AI Chief Blasts Anthropic for Training Claude to Act Conscious

Mustafa Suleyman doesn’t mince words. The Microsoft AI chief has taken direct aim at rival…

13 hours ago

This website uses cookies.